Introduction
Gastric cancer is the second most common cancer worldwide and remains a significant global health problem, with widely varying geographical distribution [1] . It is the most common cancer in the Sultanate of Oman, with an age-adjusted annual incidence of 54/100,000 among males and 22/100,000 among females in 2002 [2] .
Gastric carcinogenesis is a complex process resulting from interactions between genetic and environmental factors [3] . Dietary habits, such as smoking, alcohol consumption, and low intake of fruits or vegetables, are strongly implicated [4, 5] . Helicobacter pylori infection is an established risk factor for gastric cancer, triggering chronic inflammation of the stomach and leading to stepwise development of the malignancy [5, 6] . More recently, genetic risk factors such as polymorphisms of the interleukin-1b gene (IL-1B) and interleukin-1 receptor antagonist gene (IL-1RN) were associated with increased gastric cancer risk. IL-1B is a proinflammatory cytokine and a powerful inhibitor of gastric acid secretion that plays a major role in initiating and amplifying the inflammatory response to H. pylori infection [7] [8] [9] . IL-1RN encodes the IL-1 receptor antagonist (IL1ra), an antiinflammatory cytokine that competitively binds to IL-1 receptors but does not elicit a response, thereby modulating the potentially damaging effects of IL-1.
The genes of the IL-1 family, IL-1A, IL-1B, and IL-1RN, are clustered on the long arm of human chromosome 2. Three diallelic polymorphisms in IL-1B have been reported at -511, -31, and +3954 basepairs (bp) from the transcription start site [10] . The IL-1RN gene has a penta-allelic 86-bp variable tandem repeat in the second intron, resulting in a short allele (IL-1RN*2, with two repeats) or long alleles (IL-1RN*L, with three to six repeats) [11] . A single T-to-C base variation occurs at position -2018 in exon 2 of IL-1RN, with the rarer allele -IL-1RN -2018 allele 2 -in complete linkage disequilibrium with allele 2 of the intronic variable number of tandem repeats (VNTR) polymorphism [12] .
Initially, El-Omar et al. reported increased risk for developing gastric cancer for individuals having the IL-1B -511T/-31C and IL-1RN*2/*2 genotypes [8] . This finding was subsequently confirmed in Caucasian, Hispanic, and some Asian studies [8, 9, [13] [14] [15] . In contrast, other Asian studies have been less conclusive on the relation between IL-1B polymorphism and gastric cancer. For example, IL-1B -31 and IL-1RN polymorphisms were not associated with a risk of gastric cancer in Koreans or Taiwanese [16, 17] . Also, the IL-1RN allele 2 gene was found to be extremely uncommon in a Japanese population, with no significant association with gastric cancer [18] . Similarly, Kato et al. found no association between the IL-1B -511 T allele and gastric cancer [19] . All of the above suggests that there is ethnic variability with regard to the IL-1B and IL-1RN polymorphisms frequency and their association with gastric cancer.
There have been no previous studies that examined the role of IL-1B and IL-1RN polymorphisms in gastric cancer in an Omani Arab population. Therefore, in this report we investigated the polymorphisms in the IL-1B gene (-31T/C, -511C/T, +3954 C/T single nucleotide changes) and in the IL-1RN gene VNTR polymorphism as well as IL-1RN -2018 T/C single nucleotide change and gastric cancer susceptibility in Omani Arab patients.
Materials and methods

Study subjects
The study population consisted of a series of consecutive unrelated gastric cancer patients diagnosed in three main hospitals in the Sultanate of Oman (Sultan Qaboos University Hospital, Royal Hospital, and Sohar Hospital) from January 2002 to May 2005. The control group was composed of subjects of the same ethnic and geographical origin as the patients. They were apparently healthy community-based subjects. The Medical Research and Ethics Committee of the College of Medicine of Sultan Qaboos University approved the study design. The study subjects gave informed consent prior to participation in the study.
Genotyping method
Blood (10 ml)was collected in an EDTA tube and stored frozen until DNA extraction. DNA was extracted from whole blood using a commercial DNA blood kit (Puregene DNA purification kit; Gentra, Minneapolis, MN, USA) and stored until used for genotyping.
The IL-1B -31, -511, +3954 polymorphisms and IL-1RN -2018 polymorphism were genotyped using Flourogenic 5-nuclease assay (TaqMan allelic discrimination test). Primers and SNP-specific dual fluorogenic probes labeled with Fam(6-carboxyflourescein) and Vic as a reporter and Tamra as a quencher (Applied Biosystems, Warrington Cheshire, UK) were used to determine the various alleles, as shown in Table 1 . Polymerase chain reaction (PCR) cycling conditions (ABI PRISM 7000; Applied Biosystems) were as follows: 50°C for 2 min and 95°C for 10 min, followed by 40 cycles of 95°C for 15 s and 62°C, 61°C, and 64°C for 1 min annealing temperatures for IL-1B -31, and +3954, and IL-1RN -2018, respectively. The different alleles were discriminated according to the fluorescence intensity of Fam and Vic.
For VNTR polymorphisms, the DNA was amplified using primers (Table 1) flanking the 86-bp tandem repeat polymorphic region in intron 2 of IL-1RN. The PCR was performed with 1 cycle of 5 min at 94°C; 35 cycles of 30 s at 94°C, 30 s at 50°C, and 30 s at 72°C; followed by 5 min at 72°C. PCR products were electrophoresed on a 2% agarose gel and visualized under ultraviolet light after staining with ethidium bromide. The IL-1RN alleles were coded as previously described: allele 1, four repeats; allele 2, two repeats; allele 3, five repeats; allele 4, three repeats; and allele 5, six repeats. The IL-1RN alleles were further divided into two categories: long genotype (L > three repeats; alleles 1, 3, 4, 5) and short genotype (2 = two repeats; allele 2). The genotypes were further classified as L/L, L/*2, and *2/*2 [20, 21] .
Helicobacter pylori status analysis
The H. pylori status was determined on serum specimens of all gastric cancer patients and 89 control subjects using enzyme linked immunosorbent assay (ELISA) for H, pylori immunoglobulin G (IgG) antibody (Inova Diagnostics, San Diego, CA, USA). Negative status was defined as a concentration below 20 U/ml as per the supplier's instructions.
Statistical analyses
The genotype distributions of various polymorphic loci in controls were compared to that expected from the Hardy-Weinberg equilibrium by c 2 tests. The difference in frequency distributions of genotypes between the patient and the control groups was also tested by c 2 test. Age-and-sex adjusted odds ratios (ORs) and 95% confidence intervals (CIs) were calculated by logistic regression analysis. P < 0.05 was considered statistically significant. Analysis of data was performed using SPSS 10.0 software.
Results
A total of 118 gastric cancer patients and 245 healthy controls were included. The intestinal and diffuse histology subtypes were found in 63 and 55 gastric cancer specimens, respectively. The mean age of the gastric cancer patients was 56.5 years (median ± SD 56.0 ± 12.3) and 29.3 years (median ± SD 26.0 ± 10.8) for the control population. The percentage of males was 55.1% in the cancer group and 56.9% among the control subjects. Our control subjects were closely matched in terms of sex, but they were younger than the patients. To minimize the possible confounding effects caused by age, we adjusted the odd ratio calculations for age and sex as described previously [20, 22] .
Genotype frequencies and gastric cancer risk
The frequencies of IL-1B and IL-1RN genotypes are shown in Tables 2 and 3 . IL-1RN and IL-1B allelic distributions did not deviate significantly from those expected in a Hardy-Weinberg equilibrium for control subjects. The frequency of IL-1B -31 C allele in the Omani population was 48% compared with 34% and 51% in Caucasian and Asian populations, respectively [8, 16, 22] . IL-1B -511 polymorphism was studied in all gastric cancer patients and 156 controls. Linkage disequilibrium between the T-to-C transition at IL-1B -31 and the C-to-T transition at IL-1B -511 was confirmed in Omani patients and their controls (r 2 for patients = 0.88; r 2 for controls = 0.93) (data not shown). IL-1B +3954 T allele frequency was 30% compared to 23% and 6% in Caucasian and Asian populations, respectively [20, 22] . The frequency of the IL-1RN*2 allele was 15% compared with 26% and 6% in Caucasian and Asian populations, respectively [16, 22] . The single nucleotide polymorphism at T-to-C basepair change at position -2018 in exon 2 is in linkage disequilibrium with allele 2 of the intronic VNTR polymorphism in Omani gastric cancer patients (r 2 = 0.98) and controls (r 2 = 1.0), as shown in Table 3 .
The carriage of IL-1RN* 2 allele was associated with increased risk of gastric cancer (OR = 2.2, 95% CI = 1.1-2.7, P = 0.04) ( Table 3 ). The homozygous ILRN *2/*2 genotype was found in only three patients and was not associated with gastric cancer (P = 0.3). The heterozygote genotype *2/L was associated with increased risk, with OR = 2.6 (95% CI = 1.2-4.6, P = 0.015). There was no significant association between the other studied polymorphisms and gastric cancer risk, as the calculation of odds ratio did not reach statistical significance with any genotype (Table 2) .
Combined IL-1RN and IL-1B genotypes and gastric cancer risk
The age-and sex-adjusted odds ratios of the combined genotype analysis of IL-1B -31 or +3945 and IL-1RN were estimated as previously described [21] ; the results are shown in Table 4 . A significant gastric cancer risk association (OR = 7.9) was observed in the combined genotype of homozygote wild IL-1B -31 TT and IL-1RN *2/L (P = 0.02). There was a twofold increase in gastric cancer risk for IL-1B -31 *C allele carriers and IL-1RN *2 allele carriers, but it was not statistically significant (P = 0.17). There was also about a threefold increase in gastric cancer risk for the combined genotype of homozygous wild IL-1B -3954 CC and IL-1RN *2 and combined genotype IL-1B -3954 *T allele carrier and *2 allele carrier (P = 0.05).
Interaction between H. pylori and IL-1B genotypes
All 118 gastric cancer patients and 89 control subjects were tested for Helicobacter serology. The rates of positive serology were 56.8% for the cancer group and 59.5% for the control group. There was no change in the lack of association between IL-1B -31 and +3945 and gastric cancer. The risk for IL-1RN* 2 allele carriers increased by 3.5 (95% CI = 1.0-11.9, P = 0.04) as shown in Table 5 . The gastric cancer risk was more evident for 
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Interaction between intestinal histology subtype and IL-1B genotypes
The subclassification of gastric cancer histology into intestinal and nonintestinal did not show any effect on gastric cancer risk for any of the genotypes studied (data not shown).
Discussion
We investigated the association between GC and IL-1B -31, -511, +3954 polymorphisms and single base -2018
polymorphisms and the VNTR polymorphism of IL-1RN gene in an Omani Arab population, an ethnic group in which the association between gastric cancer and these polymorphisms has not been studied previously.
Our results showed that the presence of IL-1RN*2 allele independently increases the risk of gastric cancer, with an OR of 2.2 in the Omani population. This finding is in agreement with other reports that also demonstrated that the presence of IL-1RN*2 increased the risk of gastric cancer [8, 13, 14] . Most of these studies reported this association with an IL-1RN*2 homozygous genotype; however, we found this association with a heterozygous genotype, which is consistent with four other studies from Brazil, Taiwan, and Italy that found the same association between IL-1RN*2 allele carriers and gastric cancer [21] [22] [23] [24] . The variation in IL-1RN gastric cancer predisposition risk between Asian studies and others including ours may be due in part to the variation in frequency of the IL1-RN*2 genotype in the populations in question. The IL-1RN*2 allele is uncommon in Asians, for whom frequencies of around 6% are reported, compared to 26% in Caucasians and 15% in our study [8, 16] .
The biological function of secreted IL-1RN is to inhibit competitively the binding of circulating IL-1B to cell-surface receptors and to counterbalance the potentially injurious proinflammatory effects of IL-1B. The presence of IL-1RN*2 was associated with severe acute and chronic inflammation in the gastric mucosa [25] . Moreover, an altered IL-1RN/IL-1B ratio was found to be associated with a heightened and prolonged proinflammatory immune response [26, 27] . This view is further supported by our data showing that the combined analysis the gastric cancer risk was particularly increased among carriers of the IL-1RN*2 allele, who were also homozygous for the wild IL-1B -31 T allele (OR = 7.9), suggesting an interaction between these two genotypes.
We found no evidence of increased gastric cancer risk among IL-1B -31C carriers or IL-1B +3954 T carriers. In other studies, IL-1B -31 C polymorphisms have been shown to be associated with increased risk of gastric cancer in Caucasian and Hispanic populations [8, 15] . However, these results could not be reproduced in studies performed in Japanese, Korean, or Taiwanese subjects [16, 17, 19] . This indicates that our results are consistent with those reported in Asians but not those in Caucasians.
In our study population, the IL-1B -31 and IL-1B -511 polymorphisms suggested that these polymorphisms were tightly linked, in accord with earlier studies [8, 13] . Linkage disequilibrium between the T-to-C transition at IL-1B -31 and the C-to-T transition at IL-1B -511 was confirmed in Omani patients and controls.
The single nucleotide polymorphism at T-to-C basepair change at position -2018 in exon 2 is completely associated with allele 2 of the intronic VNTR polymorphism in Omani gastric cancer patients [12] .
With regard to the interaction between H. pylori infection and IL-1B genotype polymorphism, we found no difference in the prevalence of H. pylori infection in the control and case groups, with positive serology rates of 59.5% and 56.8%, respectively. The gastric cancer risk was more evident for the heterozygous IL-1RN 2/L (OR = 5.4; 95% CI = 1. 4-20.8) . Similarly, the risk for IL-1RN2* carriers increased by 3.5 (95% CI = 1.0-11.9; P = 0.04). This suggests an interaction between concomitant H. pylori infection and IL-1RN2* carrier status. The immune regulatory role of the antiinflammatory cytokine of IL-1RN with concomitant H. pylori infection is implicated [28] . H. pylori infection in individuals carrying the IL-1RN*2 allele results in increased production of gastric IL-1B, leading to severe and sustained inflammation, gastric atrophy, and hypochlorhydria -and ultimately to the development of gastric carcinoma [8, 9, 26] .
Conclusion
The IL-1RN polymorphism contributes significantly to the risk of gastric cancer in an Omani Arab population, confirming the findings in Caucasians, Hispanics, and Asians. This risk is further increased with concomitant H. pylori infection, which underscores the role played by host genetics in H. pylori-related gastric carcinogenesis. However, the widely reported association between IL-1B -31/-511 polymorphism and gastric cancer was not established in the Omani Arab population, supporting the ethnic differences in the effect of IL-1B polymorphism on gastric cancer carcinogenesis.
